Objective: To aid the implementation of a medication reconciliation process within a hybrid primary-specialty care setting by using qualitative techniques to describe the climate of implementation and provide guidance for future projects. Methods: Guided by McMullen et al's Rapid Assessment Process1, we performed semi-structured interviews prior to and iteratively throughout the implementation. Interviews were coded and analyzed using grounded theory2 and cross-examined for validity. Results: We identified five barriers and five facilitators that impacted the implementation. Facilitators identified were process alignment with user values, and motivation and clinical champions fostered by the implementation team rather than the administration. Barriers included a perceived limited capacity for change, diverging priorities, and inconsistencies in process standards and role definitions. Discussion: A more complete, qualitative understanding of existing barriers and facilitators helps to guide critical decisions on the design and implementation of a successful medication reconciliation process.
Objective: To aid the implementation of a medication reconciliation process within a hybrid primary-specialty care setting by using qualitative techniques to describe the climate of implementation and provide guidance for future projects. Methods: Guided by McMullen et al's Rapid Assessment Process1, we performed semi-structured interviews prior to and iteratively throughout the implementation. Interviews were coded and analyzed using grounded theory2 and cross-examined for validity. Results: We identified five barriers and five facilitators that impacted the implementation. Facilitators identified were process alignment with user values, and motivation and clinical champions fostered by the implementation team rather than the administration. Barriers included a perceived limited capacity for change, diverging priorities, and inconsistencies in process standards and role definitions. Discussion: A more complete, qualitative understanding of existing barriers and facilitators helps to guide critical decisions on the design and implementation of a successful medication reconciliation process.
Authors: Kenneth S Boockvar; Susan L Santos; Andre Kushniruk; Christopher Johnson; Jonathan R Nebeker Journal: J Hosp Med Date: 2011 Jul-Aug Impact factor: 2.960
Authors: Catherine Plaisant; Johnny Wu; A Zach Hettinger; Seth Powsner; Ben Shneiderman Journal: J Am Med Inform Assoc Date: 2015-02-08 Impact factor: 4.497
Authors: Jennifer R Pippins; Tejal K Gandhi; Claus Hamann; Chima D Ndumele; Stephanie A Labonville; Ellen K Diedrichsen; Marcy G Carty; Andrew S Karson; Ishir Bhan; Christopher M Coley; Catherine L Liang; Alexander Turchin; Patricia C McCarthy; Jeffrey L Schnipper Journal: J Gen Intern Med Date: 2008-06-19 Impact factor: 5.128
Authors: Brian J Clay; Lakshmi Halasyamani; Erin R Stucky; Jeffrey L Greenwald; Mark V Williams Journal: J Hosp Med Date: 2008 Nov-Dec Impact factor: 2.960
Authors: Blake J Lesselroth; Robert S Felder; Shawn M Adams; Phillip D Cauthers; David A Dorr; Gordon J Wong; David M Douglas Journal: J Am Med Inform Assoc Date: 2009-03-04 Impact factor: 4.497
Authors: Leonie Heyworth; Allison M Paquin; Justice Clark; Victor Kamenker; Max Stewart; Tracey Martin; Steven R Simon Journal: J Am Med Inform Assoc Date: 2013-09-13 Impact factor: 4.497
Authors: Rachel Gold; Arwen E Bunce; Deborah J Cohen; Celine Hollombe; Christine A Nelson; Enola K Proctor; Jill A Pope; Jennifer E DeVoe Journal: Mayo Clin Proc Date: 2016-04-23 Impact factor: 7.616
Authors: Michael R Gionfriddo; Yirui Hu; Bhumika Maddineni; Melissa Kern; Vanessa Hayduk; William R Kaledas; Nevan Elder; Jeffrey Border; Katie Frusciante; Maria Kobylinski; Eric A Wright Journal: JMIR Form Res Date: 2022-03-08
Authors: Blake Lesselroth; Victoria Lee Church; Kathleen Adams; Amanda Mixon; Amy Richmond-Aylor; Naomi Glasscock; Jack Wiedrick Journal: BMJ Open Qual Date: 2022-10